Post-viral atopic airway disease: pathogenesis and potential avenues for intervention

ABSTRACT Introduction: In early childhood, wheezing due to lower respiratory tract illness is often associated with infection by commonly known respiratory viruses such as respiratory syncytial virus (RSV) and human rhinovirus (RV). How respiratory viral infections lead to wheeze and/or asthma is an area of active research. Areas covered: This review provides an updated summary of the published information on the development of post-viral induced atopy and asthma and the mechanisms involved. We focus on the contribution of animal models in identifying pathways that may contribute to atopy and asthma following respiratory virus infection, different polymorphisms that have been associated with asthma development, and current options for disease management and potential future interventions. Expert commentary: Currently there are no prophylactic therapies that prevent infants infected with respiratory viruses from developing asthma or atopy. Neither are there curative therapies for patients with asthma. Therefore, a better understanding of genetic factors and other associated biomarkers in respiratory viral induced pathogenesis is important for developing effective personalized therapies.

[1]  O. Ramilo,et al.  The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. , 2018, The Lancet. Infectious diseases.

[2]  M. Grayson,et al.  Heterogeneity and the origins of asthma. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  B. Lina,et al.  Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. , 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  M. Grayson,et al.  Respiratory viral infections and atopic development: From possible mechanisms to advances in treatment , 2018, European journal of immunology.

[5]  L. Dagna,et al.  Eosinophils from Physiology to Disease: A Comprehensive Review , 2018, BioMed research international.

[6]  S. Loukides,et al.  Targeted anti-IL-13 therapies in asthma: current data and future perspectives , 2018, Expert opinion on investigational drugs.

[7]  M. Pérez‐Losada,et al.  RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NFκB signaling , 2018, Pediatric Research.

[8]  M. Grayson,et al.  Cysteinyl leukotriene receptor 1 expression identifies a subset of neutrophils during the antiviral response that contributes to postviral atopic airway disease , 2017, The Journal of allergy and clinical immunology.

[9]  H. Tsutsumi,et al.  Up-regulation of serum periostin and squamous cell carcinoma antigen levels in infants with acute bronchitis due to respiratory syncytial virus. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[10]  M. Lucero,et al.  Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study , 2017, The Lancet.

[11]  Scott T Weiss,et al.  Asthma remission: Predicting future airways responsiveness using an miRNA network. , 2017, The Journal of allergy and clinical immunology.

[12]  N. Patel,et al.  A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants , 2017, Science Translational Medicine.

[13]  A. Moreira,et al.  Thymic stromal lymphopoietin, IL-33, and periostin in hospitalized infants with viral bronchiolitis , 2017, Medicine.

[14]  P. Thomas,et al.  Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus , 2017, The Journal of Immunology.

[15]  J. Schwarze,et al.  Broad-Spectrum Inhibition of Respiratory Virus Infection by MicroRNA Mimics Targeting p38 MAPK Signaling , 2017, Molecular therapy. Nucleic acids.

[16]  T. Jartti,et al.  Rhinovirus-induced first wheezing episode predicts atopic but not nonatopic asthma at school age , 2017, Journal of Allergy and Clinical Immunology.

[17]  J. Schwarze,et al.  The Human Immune Response to Respiratory Syncytial Virus Infection , 2017, Clinical Microbiology Reviews.

[18]  P. Antal,et al.  Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy , 2017, Allergy, asthma & immunology research.

[19]  Joseph Finkelstein,et al.  Machine learning approaches to personalize early prediction of asthma exacerbations , 2017, Annals of the New York Academy of Sciences.

[20]  D. Duffy,et al.  Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies , 2016, Front. Pharmacol..

[21]  Geovanny F. Perez,et al.  Airway Secretory microRNAome Changes during Rhinovirus Infection in Early Childhood , 2016, PloS one.

[22]  K. Boyd,et al.  Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin , 2016, The Journal of allergy and clinical immunology.

[23]  A. Fryer,et al.  Human and Mouse Eosinophils Have Antiviral Activity against Parainfluenza Virus. , 2016, American journal of respiratory cell and molecular biology.

[24]  T. Casale,et al.  Characterization of asthma endotypes: implications for therapy. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[25]  R. Lamb,et al.  Taxonomy of the order Mononegavirales: update 2016 , 2016, Archives of Virology.

[26]  R. Gangnon,et al.  Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence , 2016, Journal of Allergy and Clinical Immunology.

[27]  T. Hartert,et al.  Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood , 2016, Pediatric pulmonology.

[28]  Tamekia Jones,et al.  Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33 , 2015, PLoS pathogens.

[29]  F. Baldanti,et al.  Characteristics and Their Clinical Relevance of Respiratory Syncytial Virus Types and Genotypes Circulating in Northern Italy in Five Consecutive Winter Seasons , 2015, PloS one.

[30]  I. Adcock,et al.  Role of microRNAs in allergic asthma: present and future , 2015, Current opinion in allergy and clinical immunology.

[31]  Damien Chaussabel,et al.  Democratizing systems immunology with modular transcriptional repertoire analyses , 2014, Nature Reviews Immunology.

[32]  M. Grayson,et al.  CD49d-expressing neutrophils differentiate atopic from nonatopic individuals. , 2014, The Journal of allergy and clinical immunology.

[33]  S. Madhi,et al.  Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. , 2013, The Journal of infectious diseases.

[34]  J. Banchereau,et al.  Whole Blood Gene Expression Profiles to Assess Pathogenesis and Disease Severity in Infants with Respiratory Syncytial Virus Infection , 2013, PLoS medicine.

[35]  M. Rovers,et al.  Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. , 2013, The New England journal of medicine.

[36]  S. Johnston,et al.  The emerging role of microRNAs in regulating immune and inflammatory responses in the lung , 2013, Immunological reviews.

[37]  R. Gangnon,et al.  Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. , 2012, The Journal of allergy and clinical immunology.

[38]  Jichong Huang,et al.  The -444A/C polymorphism in the LTC4S gene and the risk of asthma: a meta-analysis. , 2012, Archives of medical research.

[39]  C. Brightling,et al.  A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma , 2012, European Respiratory Journal.

[40]  Samir N. Patel,et al.  Genetic Variability of Human Respiratory Syncytial Virus A Strains Circulating in Ontario: A Novel Genotype with a 72 Nucleotide G Gene Duplication , 2012, PloS one.

[41]  A. Falus,et al.  Evaluation of a Partial Genome Screening of Two Asthma Susceptibility Regions Using Bayesian Network Based Bayesian Multilevel Analysis of Relevance , 2012, PloS one.

[42]  M. Grayson,et al.  Expression of High-Affinity IgE Receptor on Human Peripheral Blood Dendritic Cells in Children , 2012, PloS one.

[43]  David Artis,et al.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus , 2011, Nature Immunology.

[44]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[45]  P. Gergen,et al.  Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. , 2011, The New England journal of medicine.

[46]  C. Lloyd,et al.  Functions of T cells in asthma: more than just TH2 cells , 2010, Nature Reviews Immunology.

[47]  M. Grayson,et al.  Development of atopy by severe paramyxoviral infection in a mouse model. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[48]  M. Holtzman,et al.  Cutting Edge: CD49d+ Neutrophils Induce FcεRI Expression on Lung Dendritic Cells in a Mouse Model of Postviral Asthma , 2010, The Journal of Immunology.

[49]  V. Backer,et al.  Estimates of asthma heritability in a large twin sample , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[50]  P. Gustafsson,et al.  Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life , 2010, Thorax.

[51]  J. Melero,et al.  Ten Years of Global Evolution of the Human Respiratory Syncytial Virus BA Genotype with a 60-Nucleotide Duplication in the G Protein Gene , 2010, Journal of Virology.

[52]  Rob Lambkin-Williams,et al.  A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus , 2010, Proceedings of the National Academy of Sciences.

[53]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[54]  Anthony Bosco,et al.  Interactions between Innate Antiviral and Atopic Immunoinflammatory Pathways Precipitate and Sustain Asthma Exacerbations in Children1 , 2009, The Journal of Immunology.

[55]  D. Duffy,et al.  Exploring the association between severe respiratory syncytial virus infection and asthma: a registry-based twin study. , 2009, American journal of respiratory and critical care medicine.

[56]  W. Dupont,et al.  Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma. , 2009, The Journal of allergy and clinical immunology.

[57]  D. Kwiatkowski,et al.  Genetic association study for RSV bronchiolitis in infancy at the 5q31 cytokine cluster , 2009, Thorax.

[58]  H. Bisgaard,et al.  Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children. , 2008, American journal of respiratory and critical care medicine.

[59]  Wai-ming Lee,et al.  Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. , 2008, American journal of respiratory and critical care medicine.

[60]  M. Holtzman,et al.  Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia , 2007, The Journal of experimental medicine.

[61]  B. Graham,et al.  Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis , 2007, Journal of Virology.

[62]  S. Weiss,et al.  TBX21: A functional variant predicts improvement in asthma with the use of inhaled corticosteroids , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[63]  P. Helms,et al.  Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[64]  M. Galiano,et al.  Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. , 2003, The Journal of general virology.

[65]  K. Austen,et al.  Leukotriene C4 synthase: a pivotal enzyme in cellular biosynthesis of the cysteinyl leukotrienes. , 2002, Prostaglandins & other lipid mediators.

[66]  Jeffrey D. Morton,et al.  Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. , 2002, The Journal of clinical investigation.

[67]  M. Pirmohamed.  Pharmacogenetics and pharmacogenomics. , 2001, British journal of clinical pharmacology.

[68]  I. Sayers,et al.  Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast , 2000, Thorax.

[69]  F. Martinez.  Viruses and atopic sensitization in the first years of life. , 2000, American journal of respiratory and critical care medicine.

[70]  B. Kjellman,et al.  Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. , 2000, American journal of respiratory and critical care medicine.

[71]  D. Sherrill,et al.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.

[72]  O. Ramilo,et al.  Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. , 1999, The Pediatric infectious disease journal.

[73]  B. Björkstén,et al.  Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. , 1995, Pediatrics.

[74]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[75]  D. German,et al.  Development of allergy in children , 1979, Journal of Allergy and Clinical Immunology.

[76]  L. Bont,et al.  Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children , 2018 .

[77]  Carla Garcia,et al.  Respiratory Syncytial Virus Genotypes, Host Immune Profiles, and Disease Severity in Young Children Hospitalized With Bronchiolitis , 2017, The Journal of infectious diseases.

[78]  M. Grayson,et al.  Cross-linking IgE augments human conventional dendritic cell production of CC chemokine ligand 28. , 2010, The Journal of allergy and clinical immunology.

[79]  R. Peebles.  Viral infections, atopy, and asthma: is there a causal relationship? , 2004, The Journal of allergy and clinical immunology.

[80]  N. Papadopoulos,et al.  Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. , 2004, Paediatric respiratory reviews.

[81]  E. Silverman,et al.  Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.